Nuo Therapeutics Inc (NUOT) Gross Profit Margin starting from the first quarter 2026 to first quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Nuo Therapeutics Inc   (NUOT)


Nuo Therapeutics Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NUOT Gross Profit Margin (Mar 31 2026)
Q1 		(Dec 31 2025)
Q4 		(Sep 30 2025)
Q3 		(Jun 30 2025)
Q2 		(Mar 31 2025)
Q1
Y / Y Revenue Change 168.82 %
Seq. Revenue Change 30.05 %
Revenue In Millions $1.30
Gross Profit Margin 65.26 %
Gross Profit Margin Total Ranking # 1185
Gross Profit In Millions $0.85
Y / Y Gross Profit Change 133.85 %
Seq. Gross Profit Change 23.44 %


Commenting First Quarter 2026 Gross Profit Margin
Nuo Therapeutics Inc has managed to improve its Revenue sequentially to $1.30 millions by 30.05 % faster than Gross Profit increase of 23.44 % to $0.85 millions, this led to contraction in Gross Profit Margin to 65.26 %, but the Nuo Therapeutics Inc I. Quarter Gross Profit Margin remained above company average rate of 60.97%.


Observing first quarter 2026 results within Medical Equipment & Supplies industry 77 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 1107 to 1185.
Learn about Gross Margin
NUOT's Gross Profit Margin first quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 78
Healthcare Sector # 219
Overall # 1176

Gross Profit Margin Statistics
High Average Low
96.19 % 60.97 % 17.73 %
(Dec 31 2018)   (Jun 30 2016)


NUOT Gross Income Trends • More of NUOT's Profitabilty Ratios • NUOT Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
NUOT's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
NUOT's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for NUOT's Competitors
Gross Profit Margin Profit Margin for Nuo Therapeutics Inc 's Suppliers
Gross Profit Margin Profit Margin for NUOT's Customers

You may also want to know
NUOT's Annual Growth Rates NUOT's Profitability Ratios NUOT's Asset Turnover Ratio NUOT's Dividend Growth
NUOT's Roe NUOT's Valuation Ratios NUOT's Financial Strength Ratios NUOT's Gross Profit Growth
NUOT's Roa NUOT's Inventory Turnover Ratio NUOT's Growth Rates NUOT's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Mar 31 2026, within Medical Equipment & Supplies Industry Gross Profit MarginMar 31 2026 MRQ Gross ProfitMar 31 2026 MRQ Revenue
Soleno Therapeutics Inc  98.73 %$ 93.405  Millions$ 94.603  Millions
Longduoduo Co Ltd  98.24 %$ 0.184  Millions$ 0.187  Millions
Sanara Medtech Inc   96.28 %$ 25.875  Millions$ 26.875  Millions
Solana Company  95.03 %$ 3.441  Millions$ 3.621  Millions
Cvrx inc   92.80 %$ 12.881  Millions$ 13.881  Millions
Seastar Medical Holding Corp  90.71 %$ 0.449  Millions$ 0.495  Millions
Catheter Precision Inc   90.28 %$ 0.390  Millions$ 0.432  Millions
Sight Sciences Inc   89.46 %$ 16.978  Millions$ 18.978  Millions
Electrocore Inc   89.32 %$ 8.364  Millions$ 9.364  Millions
Ceribell Inc   88.52 %$ 23.122  Millions$ 26.122  Millions
Trisalus Life Sciences Inc   88.46 %$ 7.669  Millions$ 8.669  Millions
Nexalin Technology Inc   87.85 %$ 0.013  Millions$ 0.015  Millions
Delcath Systems Inc   87.63 %$ 21.258  Millions$ 24.258  Millions
Inspire Medical Systems inc   86.76 %$ 176.912  Millions$ 203.912  Millions
Neuraxis Inc   86.42 %$ 1.390  Millions$ 1.608  Millions
Electromed Inc   83.00 %$ 14.643  Millions$ 17.643  Millions
Mobia Medical Inc   82.33 %$ 9.941  Millions$ 12.074  Millions
Fonar Corporation  81.94 %$ 21.691  Millions$ 26.472  Millions
Neuropace Inc   81.86 %$ 18.048  Millions$ 22.048  Millions
Vycor Medical Inc   81.81 %$ 0.375  Millions$ 0.459  Millions
Avita Medical Inc   81.70 %$ 15.728  Millions$ 19.251  Millions
Heartflow Inc   80.83 %$ 42.164  Millions$ 52.164  Millions
Axe Compute Inc  80.83 %$ 0.029  Millions$ 0.035  Millions
Si bone inc   80.75 %$ 41.944  Millions$ 51.944  Millions
Carlsmed Inc   80.55 %$ 12.425  Millions$ 15.425  Millions
Pulmonx Corporation  80.04 %$ 16.044  Millions$ 20.044  Millions
Petvivo Holdings Inc   79.78 %$ 0.203  Millions$ 0.255  Millions
Treace Medical Concepts Inc   79.26 %$ 37.407  Millions$ 47.198  Millions
Edwards Lifesciences Corporation  78.03 %$ 1,286.000  Millions$ 1,648.000  Millions
Glaukos Corp  78.03 %$ 117.232  Millions$ 150.232  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.